Clinical Trial Update: Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and tolerance of cladribine in symptomatic pulmonary Langerhans cell histiocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis of the Lung

Drugs mentioned

• Cladribine (cladribine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Langerhans Cell Histiocytosis of Lung | Phase 2 | Status: UNKNOWN